# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001650664-24-000025
Filing Date
2024-04-16
Accepted
2024-04-16 16:25:39
Documents
49
Period of Report
2024-04-16

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | edit-20240416.htm iXBRL | DEF 14A | 1290570
6 | GRAPHIC | edit-20240416_g1.jpg | GRAPHIC | 56611
7 | GRAPHIC | edit-20240416_g10.jpg | GRAPHIC | 3974
8 | GRAPHIC | edit-20240416_g11.jpg | GRAPHIC | 3022
9 | GRAPHIC | edit-20240416_g12.jpg | GRAPHIC | 14089
10 | GRAPHIC | edit-20240416_g13.jpg | GRAPHIC | 4066
11 | GRAPHIC | edit-20240416_g14.jpg | GRAPHIC | 64483
12 | GRAPHIC | edit-20240416_g15.jpg | GRAPHIC | 233868
13 | GRAPHIC | edit-20240416_g16.jpg | GRAPHIC | 36336
14 | GRAPHIC | edit-20240416_g17.jpg | GRAPHIC | 23989
15 | GRAPHIC | edit-20240416_g18.jpg | GRAPHIC | 440754
16 | GRAPHIC | edit-20240416_g19.jpg | GRAPHIC | 158246
17 | GRAPHIC | edit-20240416_g2.jpg | GRAPHIC | 15981
18 | GRAPHIC | edit-20240416_g20.jpg | GRAPHIC | 10737
19 | GRAPHIC | edit-20240416_g21.jpg | GRAPHIC | 11156
20 | GRAPHIC | edit-20240416_g22.jpg | GRAPHIC | 11107
21 | GRAPHIC | edit-20240416_g23.jpg | GRAPHIC | 10882
22 | GRAPHIC | edit-20240416_g24.jpg | GRAPHIC | 24732
23 | GRAPHIC | edit-20240416_g25.jpg | GRAPHIC | 26025
24 | GRAPHIC | edit-20240416_g26.jpg | GRAPHIC | 24368
25 | GRAPHIC | edit-20240416_g27.jpg | GRAPHIC | 29629
26 | GRAPHIC | edit-20240416_g28.jpg | GRAPHIC | 320011
27 | GRAPHIC | edit-20240416_g29.jpg | GRAPHIC | 311441
28 | GRAPHIC | edit-20240416_g3.jpg | GRAPHIC | 6085
29 | GRAPHIC | edit-20240416_g30.jpg | GRAPHIC | 1219
30 | GRAPHIC | edit-20240416_g31.jpg | GRAPHIC | 1136
31 | GRAPHIC | edit-20240416_g32.jpg | GRAPHIC | 262914
32 | GRAPHIC | edit-20240416_g33.jpg | GRAPHIC | 254763
33 | GRAPHIC | edit-20240416_g34.jpg | GRAPHIC | 98624
34 | GRAPHIC | edit-20240416_g35.jpg | GRAPHIC | 106736
35 | GRAPHIC | edit-20240416_g4.jpg | GRAPHIC | 5546
36 | GRAPHIC | edit-20240416_g5.jpg | GRAPHIC | 3077
37 | GRAPHIC | edit-20240416_g6.jpg | GRAPHIC | 5871
38 | GRAPHIC | edit-20240416_g7.jpg | GRAPHIC | 12292
39 | GRAPHIC | edit-20240416_g8.jpg | GRAPHIC | 24813
40 | GRAPHIC | edit-20240416_g9.jpg | GRAPHIC | 16264
| Complete submission text file | 0001650664-24-000025.txt |  | 8590105

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | edit-20240416.xsd | EX-101.SCH | 4576
3 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | edit-20240416_def.xml | EX-101.DEF | 6758
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | edit-20240416_lab.xml | EX-101.LAB | 9123
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | edit-20240416_pre.xml | EX-101.PRE | 6038
52 | EXTRACTED XBRL INSTANCE DOCUMENT | edit-20240416_htm.xml | XML | 194034

Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

EIN.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37687 | Film No.: 24848127
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)